RadNet (NASDAQ:RDNT – Free Report) had its target price hoisted by Truist Financial from $80.00 to $94.00 in a research note ...

DeepHealth and CARPL.ai have established a strategic collaboration to create a unique Artificial Intelligence (AI) control system for image interpretation to ensure AI scalability, performance ...

Truist raised the firm’s price target on RadNet (RDNT) to $94 from $80 and keeps a Buy rating on the shares. The firm, which is updating its estimates to reflect Q3 earnings, raised FY24 guidance and ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $83.25, ...

Maverick Medical AI Announces Completion of The Implementation of Its Real-Time Autonomous Medical Coding Solution at RadNet ...

Sawtelle-based medical imaging company RadNet Inc. is going even deeper into the use of artificial intelligence. On Nov. 11, ...

DeepHealth, a wholly-owned subsidiary of RadNet (RDNT), has received expanded FDA 510(k) clearance for its mammography software. SmartMammo Dx, ...

LOS ANGELES, Nov. 22, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost ...

鉴于最近的发展，Truist Securities已经修订了RadNet 2024年至2026年的调整后EBITDA估计。新的估计为2024年$280.4百万，高于先前的$274.0百万估计。2025年和2026年的估计分别上调至$308.0百万和$336.0百万，高于先前的$300.0百万和$325.0百万预测。

The raised price target and maintained Buy rating reflect a positive outlook on RadNet (NASDAQ:RDNT)'s financial health and growth potential, particularly in the wake of its third-quarter performance ...

4 analysts have expressed a variety of opinions on RadNet (NASDAQ:RDNT) over the past quarter, offering a diverse set of opinions from bullish to bearish. The table below provides a snapshot of ...

The clearance enables RadNet’s DeepHealth and GE HealthCare collaboration to bring together the SmartMammo and Senographe Pristina solutions and transform breast cancer diagnosis. SOMERVILLE ...